Significant adverse effect unlikely with doses of different COVID-19 vaccines, but further scrutiny…
It, however, clarified that both doses administered to an individual should be of the same vaccine as per the existing protocol
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVAXIN
Bharat Biotech and Gujarat Covid Vaccine Consortium sign MoU for drug substance of COVAXIN
If everything goes as per the schedule, the drug substance would be available from August 2021
Paediatric trials of Covaxin are likely to start from June 1: Dr Raches Ella
Bharat Biotech is ramping up its manufacturing capacity to 700 million doses which are likely to be achieved by the end of this…
Bharat Biotech ramps up COVAXIN production volumes by additional 200 million
Product availability at Ankleshwar to commence from Q4 2021
More pharma companies should be permitted to produce COVID-19 vaccines: Gadkari
Instead of one company, 10 more companies should be allowed to make vaccines by paying 10 per cent royalty to the original patent…
Bharat Biotech’s Karnataka facility will be able to make 4-5 cr Covaxin doses a month by Aug…
He also said that Bharat Biotech's facility in Hyderabad can produce one crore doses of COVID vaccine a month
Gujarat Government, Hester Biosciences and Omnibrx to collaborate for COVAXIN production
There are plans to produce minimum 20 million doses per month
Government to set up national platform to track and verify impact of COVID-19 vaccines
A national tracking platform will be established soon to determine the impact of the jabs against COVID-19 and the breakthrough…
Over two billion doses of COVID-19 vaccines to be available between August to December 2021: Centre…
Dr V K Paul said by the first quarter of the next year, the number is likely to be three billion
SEC recommends phase II/III clinical trials of Covaxin on 2-18 year-olds
The trial will be conducted on 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of…